Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

Budgeting for generative AI in healthcare has skyrocketed, albeit in pockets, by as much as 300% year over year. 

If a clinician you care about counts on AI to help make medical decisions, remind them: Tort law principles hold that doing so means risking liability should a patient sue over harm done.

Healthcare leaders around the U.S. might want to take notice of what’s going on in the streets of San Francisco this week.

All around the world, people are increasingly wise to the advance of AI. More than a few are growing ever more uneasy about it. And yet workers equipped with AI are both more productive and better at their jobs.

More than two-thirds of U.S. physicians have changed their minds about generative AI over the past year. In doing so, the re-thinkers have raised their level of trust in the technology to help improve healthcare.

Key collaborators across the healthcare AI life cycle now have a common set of principles to which they can hold each other. And that means everyone from developers and researchers to providers, regulators and even patients.

Bumping up hard against the reality of depleted data sources, three of AI’s top players have been acting like they’ve had no choice but to consider cutting corners.